Why did MYX fall 8.2% on 19 Mar 2026?
Mayne Pharma · Pharmaceuticals, Biotechnology & Life Sciences
What moved it
No relevant news articles directly explain the 8.19% decline in Mayne Pharma Group on 2026-03-18, leaving the cause unknown.
The news articles provided around the event date cover unrelated companies (Droneshield, CSL, Stavely Minerals, Chorus, Black Cat) and sectors, with no mention of Mayne Pharma Group or any relevant pharmaceutical/pharma-specific event. The price move is significant (4x ATR, 3.29x volume) but no direct or indirect catalyst can be identified from the available texts.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice.
The evidence
In the news
What Does the 60Mt Resource Mean for Stavely Minerals (ASX:SVY) Minerals Investors?
Kalkine · 17 Mar 2026
ChartWatch ASX Scans: Droneshield, CSL, Elsight, APA Group, Metcash, REA, Seek, Stockland, Superloop
Market Index · 19 Mar 2026
Chorus (ASX:CNU) Trading Volume Surged 207% Today: Fibre Growth and Dividend Yield in Focus
Kalkine · 19 Mar 2026
Is Black Cat (ASX:BC8) Worth Considering After 9% Decline?
Kalkine · 19 Mar 2026
Headlines link to the publisher.
Held by no ETF
Not currently held by any ETF we track.